HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 203 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $19,526,202 | -40.6% | 598,046 | +0.3% | 0.28% | -35.1% |
Q4 2022 | $32,850,179 | +12.9% | 596,192 | -9.3% | 0.44% | +4.3% |
Q3 2022 | $29,107,000 | -15.0% | 657,188 | -6.4% | 0.42% | -13.6% |
Q2 2022 | $34,240,000 | +463.3% | 702,068 | +461.8% | 0.48% | +581.7% |
Q1 2022 | $6,079,000 | +17.7% | 124,961 | +3.1% | 0.07% | +34.0% |
Q4 2021 | $5,166,000 | +4.2% | 121,161 | -6.3% | 0.05% | +6.0% |
Q3 2021 | $4,956,000 | – | 129,289 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Valor Management LLC | 11,218,033 | $496,847,000 | 95.45% |
Vivo Capital, LLC | 3,400,261 | $150,598,000 | 16.63% |
Nan Fung Group Holdings Ltd | 510,978 | $22,631,000 | 14.44% |
venBio Partners LLC | 1,125,673 | $49,856,000 | 11.54% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $11,715,000 | 3.76% |
ASHFORD CAPITAL MANAGEMENT INC | 490,768 | $21,736,000 | 3.32% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 636,485 | $28,190,000 | 2.79% |
Octagon Capital Advisors LP | 243,500 | $10,785,000 | 1.86% |
TANG CAPITAL MANAGEMENT LLC | 310,000 | $13,730,000 | 1.68% |
Lisanti Capital Growth, LLC | 248,070 | $10,987,000 | 1.47% |